Dermapharm Holding SE Bearer Shares (EUR)
DMP
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range45.28 | 46.14
52-Wk Range- | -
Last Close-
Mkt Cap (m)-
Dividend yield-
ISINDE000A2GS5D8
Volume38,052.00
Exchange VenueETR

Company Profile

Dermapharm Holding SE is a manufacturer of patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs and natural remedies. Its portfolio of products includes cosmetics, nutritional supplements and diet and medical devices.

Key Information
Price/Earning-
Price/Book-
Price/Sales-
P/CF-
Rev Growth (3 year avg)16.39
EPS Growth (3 year avg)0.66
Operating Margin % 17.08
Net Margin %11.01
Return on Equity29.07
Debt/Equity1.99

Documents

Prospectus
en 26/01/2018

Please refer to the below issuer website for further documents.

http://www.dermapharm.de

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)391.34384.84444.48467.12572.42700.88
Operating Income (m)44.2267.6486.1090.82108.86119.74
Net Income (m)-0.0612.7016.8277.7475.3277.20
Basic EPS0.000.240.311.441.411.43
Avg. Diluted Shares Outstanding (m)53.8453.8453.8453.8453.4253.84
Balance Sheet
EUR201420152016201720182019
Current Assets (m)168.54142.10156.96192.87371.24352.94
Non Current Assets (m)162.06154.56154.74222.43333.34691.93
Total Assets (m)330.60296.67311.70415.30704.581,044.87
Current Liabilities (m)97.0461.57115.4280.58146.40102.42
Total Liabilities (m)------
Total Equity (m)28.2841.1056.9273.69252.45278.65
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)54.2640.3876.7886.74159.13100.61
Capital Expenditure (m)-28.42-14.93-17.76-74.72-25.97-46.44
Figures are quoted in EUR unless stated otherwise
45.50
Last Price